Parkman Healthcare Partners’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,291
| Closed | -$548K | – | 101 |
|
|
2024
Q3 | $548K | Buy |
27,291
+404
| +2% | +$8.11K | 0.07% | 89 |
|
|
2024
Q2 | $468K | Buy |
26,887
+42
| +0.2% | +$731 | 0.06% | 86 |
|
|
2024
Q1 | $1.12M | Buy |
26,845
+1,267
| +5% | +$52.8K | 0.14% | 91 |
|
|
2023
Q4 | $643K | Sell |
25,578
-1,089
| -4% | -$27.4K | 0.09% | 85 |
|
|
2023
Q3 | $872K | Sell |
26,667
-98,886
| -79% | -$3.23M | 0.16% | 92 |
|
|
2023
Q2 | $7.31M | Buy |
125,553
+32,315
| +35% | +$1.88M | 1.27% | 26 |
|
|
2023
Q1 | $2.43M | Buy |
93,238
+14,053
| +18% | +$367K | 0.53% | 52 |
|
|
2022
Q4 | $2.36M | Buy |
79,185
+47,518
| +150% | +$1.42M | 0.63% | 53 |
|
|
2022
Q3 | $1.63M | Buy |
+31,667
| New | +$1.63M | 0.46% | 63 |
|